Bristol-Myers Agrees to Acquire ZymoGenetics

7 September 2010, 11:27 pm

Bristol-Myers Squibb said Tuesday it had agreed to acquire ZymoGenetics , the maker of a hepatitis C drug the companies were jointly developing, for $885 million, Bloomberg News reports.... Read More »

More Topics from "Articles"

• Bristol alloys company faces federal charges
• Bristol Profile: Running with Anthony 'Rabbit' Palumbo
• Bristol Township contractor ordered to trial on fraud charges
• Zacks Analyst Blog Highlights: Bristol-Myers Squibb, ZymoGenetics, Family Dollar Stores, Wal-Mart Stores and Dollar ...
• Bristol Myers Still A Good Buy After Zymogenetics Purchase
• Bristol Palin scared on 'Dancing With the Stars,' bans Levi Johnston from set
• Bristol-Myers Squibb to Present at the Morgan Stanley Global Healthcare Unplugged Conference
• News coverage of Bristol Palin speech banned
• Bristol-Myers Pays Up for ZymoGenetics